Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors
- 1 October 2002
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 144 (4) , 642-648
- https://doi.org/10.1067/mhj.2002.125009
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Use of Human Immunodeficiency Virus-1 Protease Inhibitors Is Associated With Atherogenic Lipoprotein Changes and Endothelial DysfunctionCirculation, 2001
- Highly Active Antiretroviral Therapy Decreases Mortality and Morbidity in Patients with Advanced HIV DiseaseAnnals of Internal Medicine, 2001
- Adverse effects of antiretroviral therapyThe Lancet, 2000
- Coronary Artery Disease and Human Immunodeficiency Virus InfectionClinical Infectious Diseases, 2000
- Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease InhibitorsCirculation, 1999
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998
- Severe premature coronary artery disease with protease inhibitorsThe Lancet, 1998
- Visceral abdominal-fat accumulation associated with use of indinavirThe Lancet, 1998
- Self-Report Interview Data for a Study of HIV-1 Infection among Intravenous Drug Users: Description of Methods and Preliminary Evidence on ValidityJournal of Drug Issues, 1991
- Quantification of coronary artery calcium using ultrafast computed tomographyJournal of the American College of Cardiology, 1990